{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:21:27Z","timestamp":1792034487756,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03AG067935"],"award-info":[{"award-number":["R03AG067935"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00CA237744"],"award-info":[{"award-number":["R00CA237744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jgo.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T08:32:52Z","timestamp":1645605172000},"page":"572-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper"],"prefix":"10.1016","volume":"13","author":[{"given":"Othman Salim","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazie","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallawi","family":"Torka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki A.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2022.02.005_bb0005","author":"Surveillance, Epidemiology, and End Results (SEER)"},{"key":"10.1016\/j.jgo.2022.02.005_bb0010","article-title":"Epidemiology of Non-Hodgkin\u2019s lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.jgo.2022.02.005_bb0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/bloodadvances.2021004665","article-title":"Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review","volume":"5","author":"Bataillard","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jgo.2022.02.005_bb0020","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/cam4.2998","article-title":"The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice","volume":"9","author":"Parikh","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jgo.2022.02.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-7568(21)00184-7","article-title":"Frailty assessment in the care of older people with haematological malignancies","author":"Goede","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jgo.2022.02.005_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jgo.2022.02.005_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","article-title":"Comprehensive geriatric assessment adds information to eastern cooperative oncology group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0040","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1002\/cncr.24490","article-title":"A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy","volume":"115","author":"Tucci","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2022.02.005_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/onco.13641","article-title":"Utility of the geriatric 8 for the prediction of therapy-related toxicity in older adults with diffuse large B-cell lymphoma","volume":"26","author":"Oiwa","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0050","first-page":"2833","article-title":"Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma","volume":"25","author":"Ribi","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2022.02.005_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1182\/blood-2019-129499","article-title":"Vulnerable elders Survey-13 (VES-13) predicts 1-year mortality risk in newly diagnosed non-Hodgkin lymphoma (NHL)","volume":"134","author":"Fama","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2022.02.005_bb0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjh.17384","article-title":"The use of frailty assessments in treating older adults with aggressive lymphomas","volume":"194","author":"Cordoba","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdw547","article-title":"Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) task force","volume":"28","author":"Stauder","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13347","article-title":"Comprehensive geriatric assessment in older adults with cancer: recommendations by the Italian Society of Geriatrics and Gerontology (SIGG)","volume":"51","author":"Fusco","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jgo.2022.02.005_bb0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0080","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and Management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0085","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2015.63.5839","article-title":"Use of a comprehensive geriatric assessment for the Management of Elderly Patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study","volume":"34","author":"Corre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0090","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1200\/JCO.2020.38.15_suppl.12009","article-title":"A geriatric assessment (GA) intervention to reduce treatment toxicity in older patients with advanced cancer: a University of Rochester Cancer Center NCI community oncology research program cluster randomized clinical trial (CRCT)","volume":"38","author":"Mohile","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0095","article-title":"Geriatric assessment\u2013driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0100","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1634\/theoncologist.2019-0738","article-title":"Comprehensive geriatric assessment (CGA): a simple tool for guiding the treatment of older adults with diffuse large B-cell lymphoma in China","volume":"25","author":"Bai","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0105","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0110","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2022.02.005_bb0115","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3109\/10428194.2014.953142","article-title":"Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the lymphoma Italian foundation (FIL)","volume":"56","author":"Tucci","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2022.02.005_bb0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1634\/theoncologist.2016-0260","article-title":"A host-dependent prognostic model for elderly patients with diffuse large B-cell lymphoma","volume":"22","author":"Miura","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-018-3551-y","article-title":"Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma","volume":"98","author":"Sakurai","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2022.02.005_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2011.08934.x","article-title":"Analysis of very elderly (>\/=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome","volume":"156","author":"Nabhan","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ejh.13457","article-title":"Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy","volume":"105","author":"Chou","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0150","article-title":"Clinical impact of comprehensive geriatric assessment in patients aged 80 years and older with diffuse large B-cell lymphoma receiving rituximab-mini-CHOP: a single-institute retrospective study","author":"Yamasaki","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jgo.2022.02.005_bb0155","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3324\/haematol.2019.245803","article-title":"Geriatric assessment in older patients with a hematologic malignancy: a systematic review","volume":"105","author":"Scheepers","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2022.02.005_bb0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hon.2233","article-title":"Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor","volume":"34","author":"Bairey","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2005.05508.x","article-title":"A population-based study of severity of comorbidity among patients with non-Hodgkin\u2019s lymphoma: prognostic impact independent of international prognostic index","volume":"129","author":"Janssen-Heijnen","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jha2.61","article-title":"Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: results from prospective trials of the German high-grade Non-Hodgkin\u2019s lymphoma study group","volume":"1","author":"Hohloch","year":"2020","journal-title":"eJHaem"},{"key":"10.1016\/j.jgo.2022.02.005_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.leukres.2018.07.014","article-title":"Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"71","author":"Kim","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.jgo.2022.02.005_bb0180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1634\/theoncologist.2017-0361","article-title":"Validation and refinement of the age, comorbidities, and albumin index in elderly patients with diffuse large B-cell lymphoma: an effective tool for comprehensive geriatric assessment","volume":"23","author":"Liu","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3109\/10428190903318311","article-title":"Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy","volume":"50","author":"Chihara","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2022.02.005_bb0190","article-title":"Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies","author":"Gebauer","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12285","article-title":"Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"93","author":"Camus","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/annonc\/mdt594","article-title":"The role of body mass index in survival outcome for lymphoma patients: US intergroup experience","volume":"25","author":"Hong","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0205","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/10428194.2013.816421","article-title":"Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"55","author":"Lanic","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2022.02.005_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jgo.2022.02.005_bb0215","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejca.2005.01.010","article-title":"Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven cancer registry","volume":"41","author":"van Spronsen","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2022.02.005_bb0220","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood.V128.22.3049.3049","article-title":"The elderly project by the Fondazione Italiana Linfomi (FIL): a prospective multidimensional assessment of elderly patients with diffuse large B-cell lymphoma","volume":"128","author":"Merli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2022.02.005_bb0225","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.20.02465","article-title":"Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi","volume":"39","author":"Merli","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0230","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0235","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jgo.2019.04.016","article-title":"A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer","volume":"10","author":"van Walree","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bjh.17554","article-title":"Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B-cell lymphoma","volume":"194","author":"Lee","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jgo.2015.02.005","article-title":"Estimating the risk of chemotherapy toxicity in older patients with cancer: the role of the vulnerable elders Survey-13 (VES-13)","volume":"6","author":"Luciani","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0250","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.6004\/jnccn.2015.0180","article-title":"Screening performance for frailty among older patients with cancer: a cross-sectional observational study of two approaches","volume":"13","author":"Okuyama","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jgo.2022.02.005_bb0255","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21422","article-title":"Developing a cancer-specific geriatric assessment: a feasibility study","volume":"104","author":"Hurria","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2022.02.005_bb0260","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","article-title":"Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0265","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1182\/blood-2018-99-115400","article-title":"Functional predictors of chemotherapy toxicity in elderly lymphoma patients: a prospective pilot study","volume":"132","author":"Prica","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2022.02.005_bb0270","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3747\/co.26.4869","article-title":"Utility of a chemotherapy toxicity prediction tool for older patients in a community setting","volume":"26","author":"Mariano","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0275","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.2011.35.7442","article-title":"Predictors of early death risk in older patients treated with first-line chemotherapy for cancer","volume":"30","author":"Soubeyran","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0280","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/10428194.2015.1091933","article-title":"Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: results of the CLL9 trial of the German CLL study group","volume":"57","author":"Goede","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2022.02.005_bb0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bjh.17283","article-title":"A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)","volume":"193","author":"Boccomini","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgo.2013.04.003","article-title":"A retrospective study on 73 elderly patients (\u226575years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment","volume":"4","author":"Marchesi","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0295","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood-2019-123027","volume":"134","author":"Spina","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2022.02.005_bb0300","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2003.99.210","article-title":"Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan","volume":"21","author":"Bernardi","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0305","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1634\/theoncologist.2011-0417","article-title":"Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma","volume":"17","author":"Spina","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0310","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1634\/theoncologist.2011-0355","article-title":"Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA","volume":"17","author":"Olivieri","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2022.02.005_bb0315","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.clml.2018.11.013","article-title":"Adjusted chemotherapy according to frailty status in elderly patients with diffuse large B-cell lymphoma: experience from a single referral Center in Mexico City","volume":"19","author":"Lastra-German","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jgo.2022.02.005_bb0320","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.278802","article-title":"Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies","author":"DuMontier","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2022.02.005_bb0325","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/ejh.13570","article-title":"Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies","volume":"106","author":"Garric","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0330","article-title":"Using geriatric assessment to guide conversations regarding comorbidities among older patients with advanced cancer","volume":"Op2100196","author":"Kleckner","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jgo.2022.02.005_bb0335","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.21.00165","article-title":"Decision making in older adults with cancer","volume":"39","author":"DuMontier","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0340","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.21.00242","article-title":"Advances in management for older adults with hematologic malignancies","volume":"39","author":"Rosko","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0345","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1200\/JCO.2021.39.15_suppl.12043","article-title":"Evaluating the role of baseline geriatric assessment in predicting adherence to oral targeted therapies and outcomes in older adults with non-Hodgkin lymphoma","volume":"39","author":"Akhtar","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.02.005_bb0350","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jgo.2020.09.031","article-title":"Electronic FRAIL score may predict treatment outcomes in older adults with myeloma","volume":"12","author":"Chan","year":"2021","journal-title":"J Geriatr Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:02:20Z","timestamp":1778832140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406822000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1879406822000200"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2022.02.005","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}